Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Tirzepatide has been approved for T2D management - the mean HbA1c reduction in SURPASS programme ranged between 1.9 and 2.6% across the trials and 4069% of participants achieved 10% WL with the higher doses (10 and 15 mg), despite that there was no additional support for lifestyle intervention [16, 43]
Its still a good choice if youre really counting your pennies, but as well see below, its best price is only about $15 less per bottle than the best price you can get on Focus Support
Krajnc N, Itariu B, Macher S, et al
PMID 10760156
US$ 29.06
US$ 20.27
US$ 27.79
US$ 20.55
